Author

Vijay M. Gokhale

University of ArizonaORCID 0000-0003-2807-4741Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

A. Philip McMahon· 1 shared Aditi Mandar Atmasidha· 1 shared Alan R. PrescottiD· 1 shared Alessandra Fistrovich· 1 shared Amol M. PatwardhaniD· 1 shared Amy Dunne MilleriD· 1 shared Anthony J. ChalmersiD· 1 shared Aubin MoutaliD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Philip McMahon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 26, 2025

Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signalling

Vasudha Tandon, Alessandra Fistrovich, Joaquina Nogales…·Sourav Banerjee

This paper designs and evaluates Dyr726, a brain-penetrant multi-kinase inhibitor that targets PI3Kα, receptor tyrosine kinases, and WNT signaling, showing efficacy in preclinical cancer models.

DOI 10.1101/2025.03.26.645490

mouseexperimental assay

𝕏 PostBluesky

NeurosciencePainPeer-reviewedFeb 5, 2019

Targeting the CaV - interaction yields a selective antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy

Rajesh Khanna, Jie Yu, Xiao-Fang Yang…·May Khanna

The paper identifies a novel CaV2.2 channel antagonist with broad antinociceptive effects and reduced side effects in pain models.

43 citations

ratexperimental assay

𝕏 PostBluesky